The increased risk of breast cancer death in young versus middle-aged women was significant during the earlier part of the studied period and mainly noted in tumors with favorable characteristics, namely: small tumor size, low grade, Her2-negativity, and no LVI. Here, ERBB2 is linked to breast carcinoma.